230 related articles for article (PubMed ID: 20696767)
1. Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation.
Chen YW; Wang JK; Chou FP; Chen CY; Rorke EA; Chen LM; Chai KX; Eckert RL; Johnson MD; Lin CY
J Biol Chem; 2010 Oct; 285(41):31755-62. PubMed ID: 20696767
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin regulates matriptase activity involved in plasmin generation, syndecan shedding, and HGF activation in keratinocytes.
Chen YW; Xu Z; Baksh AN; Wang JK; Chen CY; Swanson R; Olson ST; Kataoka H; Johnson MD; Lin CY
PLoS One; 2013; 8(5):e62826. PubMed ID: 23675430
[TBL] [Abstract][Full Text] [Related]
3. Targeted deletion of HAI-1 increases prostasin proteolysis but decreases matriptase proteolysis in human keratinocytes.
Lu DD; Gu Y; Li SA; Barndt RJ; Huang SM; Wang JK; Su HC; Johnson MD; Lin CY
Hum Cell; 2021 May; 34(3):771-784. PubMed ID: 33486722
[TBL] [Abstract][Full Text] [Related]
4. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
[TBL] [Abstract][Full Text] [Related]
5. Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin.
Lee SP; Kao CY; Chang SC; Chiu YL; Chen YJ; Chen MG; Chang CC; Lin YW; Chiang CP; Wang JK; Lin CY; Johnson MD
PLoS One; 2018; 13(2):e0192632. PubMed ID: 29438412
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation.
Netzel-Arnett S; Currie BM; Szabo R; Lin CY; Chen LM; Chai KX; Antalis TM; Bugge TH; List K
J Biol Chem; 2006 Nov; 281(44):32941-5. PubMed ID: 16980306
[TBL] [Abstract][Full Text] [Related]
7. Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
Szabo R; Uzzun Sales K; Kosa P; Shylo NA; Godiksen S; Hansen KK; Friis S; Gutkind JS; Vogel LK; Hummler E; Camerer E; Bugge TH
PLoS Genet; 2012; 8(8):e1002937. PubMed ID: 22952456
[TBL] [Abstract][Full Text] [Related]
8. Insights into the regulation of the matriptase-prostasin proteolytic system.
Holt-Danborg L; Skovbjerg S; Goderum KW; Nonboe AW; Stankevic E; Frost ÁK; Vitved L; Jensen JK; Vogel LK
Biochem J; 2020 Nov; 477(22):4349-4365. PubMed ID: 33094801
[TBL] [Abstract][Full Text] [Related]
9. Matriptase and prostasin proteolytic activities are differentially regulated in normal and wounded skin.
Chang SC; Chiang CP; Lai CH; Du PA; Hung YS; Chen YH; Yang HY; Fang HY; Lee SP; Tang HJ; Wang JK; Johnson MD; Lin CY
Hum Cell; 2020 Oct; 33(4):990-1005. PubMed ID: 32617892
[TBL] [Abstract][Full Text] [Related]
10. Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation.
Lai CH; Lai YJ; Chou FP; Chang HH; Tseng CC; Johnson MD; Wang JK; Lin CY
PLoS One; 2016; 11(4):e0152904. PubMed ID: 27043831
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
Skovbjerg S; Holt-Danborg L; Nonboe AW; Hong Z; Frost ÁK; Schar CR; Thomas CC; Vitved L; Jensen JK; Vogel LK
Biochem J; 2020 May; 477(9):1779-1794. PubMed ID: 32338287
[TBL] [Abstract][Full Text] [Related]
12. The matriptase-prostasin proteolytic cascade in epithelial development and pathology.
Miller GS; List K
Cell Tissue Res; 2013 Feb; 351(2):245-53. PubMed ID: 22350849
[TBL] [Abstract][Full Text] [Related]
13. Targeted HAI-2 deletion causes excessive proteolysis with prolonged active prostasin and depletion of HAI-1 monomer in intestinal but not epidermal epithelial cells.
Barndt RB; Lee MJ; Huang N; Lu DD; Lee SC; Du PW; Chang CC; Tsai PB; Huang YK; Chang HM; Wang JK; Lai CH; Johnson MD; Lin CY
Hum Mol Genet; 2021 Sep; 30(19):1833-1850. PubMed ID: 34089062
[TBL] [Abstract][Full Text] [Related]
14. Increased matriptase zymogen activation in inflammatory skin disorders.
Chen CJ; Wu BY; Tsao PI; Chen CY; Wu MH; Chan YL; Lee HS; Johnson MD; Eckert RL; Chen YW; Chou F; Wang JK; Lin CY
Am J Physiol Cell Physiol; 2011 Mar; 300(3):C406-15. PubMed ID: 21123732
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1.
Xu H; Xu Z; Tseng IC; Chou FP; Chen YW; Wang JK; Johnson MD; Kataoka H; Lin CY
Am J Physiol Cell Physiol; 2012 Jan; 302(2):C453-62. PubMed ID: 22031598
[TBL] [Abstract][Full Text] [Related]
16. Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase.
Friis S; Godiksen S; Bornholdt J; Selzer-Plon J; Rasmussen HB; Bugge TH; Lin CY; Vogel LK
J Biol Chem; 2011 Feb; 286(7):5793-802. PubMed ID: 21148558
[TBL] [Abstract][Full Text] [Related]
17. Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition.
Wang JK; Lee MS; Tseng IC; Chou FP; Chen YW; Fulton A; Lee HS; Chen CJ; Johnson MD; Lin CY
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C459-70. PubMed ID: 19535514
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pericellular proteolysis by hepatocyte growth factor activator inhibitor type 1 (HAI-1) in trophoblast cells.
Kohama K; Kawaguchi M; Fukushima T; Lin CY; Kataoka H
Hum Cell; 2012 Dec; 25(4):100-10. PubMed ID: 23248048
[TBL] [Abstract][Full Text] [Related]
19. Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain.
Lee MS; Tseng IC; Wang Y; Kiyomiya K; Johnson MD; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C95-105. PubMed ID: 17344310
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of hepatocyte growth factor activator inhibitor-1 by membrane-type MMP-1 activates matriptase.
Domoto T; Takino T; Guo L; Sato H
Cancer Sci; 2012 Mar; 103(3):448-54. PubMed ID: 22118498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
